Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

238 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A patent review of MAPK inhibitors (2018 - present).
Wydra VR, Ditzinger RB, Seidler NJ, Hacker FW, Laufer SA. Wydra VR, et al. Among authors: laufer sa. Expert Opin Ther Pat. 2023 Jan-Jun;33(6):421-444. doi: 10.1080/13543776.2023.2242584. Epub 2023 Aug 1. Expert Opin Ther Pat. 2023. PMID: 37501497 Review.
p38 MAPK inhibitors: a patent review (2012 - 2013).
Bühler S, Laufer SA. Bühler S, et al. Among authors: laufer sa. Expert Opin Ther Pat. 2014 May;24(5):535-54. doi: 10.1517/13543776.2014.894977. Epub 2014 Mar 10. Expert Opin Ther Pat. 2014. PMID: 24611721 Review.
c-Jun N-terminal kinase inhibitors: a patent review (2010 - 2014).
Gehringer M, Muth F, Koch P, Laufer SA. Gehringer M, et al. Among authors: laufer sa. Expert Opin Ther Pat. 2015;25(8):849-72. doi: 10.1517/13543776.2015.1039984. Epub 2015 May 19. Expert Opin Ther Pat. 2015. PMID: 25991433 Review.
An updated patent review of p38 MAP kinase inhibitors (2014-2019).
Haller V, Nahidino P, Forster M, Laufer SA. Haller V, et al. Among authors: laufer sa. Expert Opin Ther Pat. 2020 Jun;30(6):453-466. doi: 10.1080/13543776.2020.1749263. Epub 2020 Apr 20. Expert Opin Ther Pat. 2020. PMID: 32228113 Review.
Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological Activity.
Flury P, Breidenbach J, Krüger N, Voget R, Schäkel L, Si Y, Krasniqi V, Calistri S, Olfert M, Sylvester K, Rocha C, Ditzinger R, Rasch A, Pöhlmann S, Kronenberger T, Poso A, Rox K, Laufer SA, Müller CE, Gütschow M, Pillaiyar T. Flury P, et al. Among authors: laufer sa. ACS Pharmacol Transl Sci. 2024 Jan 19;7(2):493-514. doi: 10.1021/acsptsci.3c00313. eCollection 2024 Feb 9. ACS Pharmacol Transl Sci. 2024. PMID: 38357286
Correction to "Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological Activity".
Flury P, Breidenbach J, Krüger N, Voget R, Schäkel L, Si Y, Krasniqi V, Calistri S, Olfert M, Sylvester K, Rocha C, Ditzinger R, Rasch A, Pöhlmann S, Kronenberger T, Poso A, Rox K, Laufer SA, Müller CE, Gütschow M, Pillaiyar T. Flury P, et al. Among authors: laufer sa. ACS Pharmacol Transl Sci. 2024 Mar 6;7(4):1195-1196. doi: 10.1021/acsptsci.4c00095. eCollection 2024 Apr 12. ACS Pharmacol Transl Sci. 2024. PMID: 38633592 Free article.
238 results